Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

GANCICLOVIR

GANCICLOVIR

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview GANCICLOVIR is listed in Drugs@FDA under application 076457 (ANDA).

Marketing status: Discontinued Active ingredient GANCICLOVIR Form and strength CAPSULE;ORAL - 250MG Sponsor RANBAXY LABS LTD Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview GANCICLOVIR is listed in Drugs@FDA under application 076457 (ANDA). Marketing status: Discontinued Active ingredient GANCICLOVIR Form and strength CAPSULE;ORAL - 250MG Sponsor RANBAXY LABS LTD Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.